Predictors of pulmonary hypertension after atrial septal defect closure: Impact of atrial fibrillation

dc.authorid0000-0003-0364-2239
dc.contributor.authorCelik, Mehmet
dc.contributor.authorYılmaz, Yusuf
dc.contributor.authorKup, Ayhan
dc.contributor.authorKahyaoglul, Muzaffer
dc.contributor.authorKaragoz, Ali
dc.contributor.authorOzdemir, Nihal
dc.contributor.authorKaymaz, Cihangir
dc.date.accessioned2025-05-10T19:58:07Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground: In this study, we aimed to evaluate the course of pulmonary artery systolic pressure, to identify factors associated with pulmonary arterial hypertension, and to determine the impact of atrial septal defect closure on clinical outcomes in long-term follow-up. Methods: Between March 2008 and August 2020, a total of 547 adult patients (193 males, 354 females; median age: 37 years; range, 27.5 to 47 years) with secundum atrial septal defect were retrospectively analyzed. Of these patients, 304 underwent percutaneous defect closure and 243 underwent isolated surgical repairs. Pulmonary arterial hypertension was defined as a non-invasively estimated pulmonary artery systolic pressure of >= 40 mmHg at the final follow-up after atrial septal defect closure. Factors associated with pulmonary arterial hypertension were analyzed. Results: Sixty-nine (12.6%) patients presented with pulmonary arterial hypertension at the final follow-up. A total of 35 (6.4%) patients had persistent atrial fibrillation before atrial septal defect closure, and 22 of these 35 patients had pulmonary arterial hypertension during long-term follow-up. Older age at the time of atrial septal defect closure (HR: 4.76; 95% CI: 2.68-8.44; p<0.001), the presence of persistent atrial fibrillation (HR: 2.18; 95% CI: 1.21-3.91; p=0.009), and greater right ventricular basal diameter (HR: 4.78; 95% CI: 2.57-8.84; p<0.001) were found to be associated with late pulmonary arterial hypertension. Conclusion: The presence of persistent atrial fibrillation may be used to predict patients at higher risk for pulmonary arterial hypertension after atrial septal defect closure.
dc.identifier.doi10.5606/tgkdc.dergisi.2022.23639
dc.identifier.endpage353
dc.identifier.issn1301-5680
dc.identifier.issue3
dc.identifier.pmid36303690
dc.identifier.scopusqualityQ3
dc.identifier.startpage344
dc.identifier.trdizinid1173427
dc.identifier.urihttps://doi.org/10.5606/tgkdc.dergisi.2022.23639
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1173427
dc.identifier.urihttps://hdl.handle.net/20.500.14730/13428
dc.identifier.volume30
dc.identifier.wosWOS:000835181100004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBaycinar Medical Publ-Baycinar Tibbi Yayincilik
dc.relation.ispartofTurk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectAtrial septal defect
dc.subjectpersistent atrial fibrillation
dc.subjectpulmonary hypertension
dc.subjectsurgical closure
dc.subjecttranscatheter closure
dc.titlePredictors of pulmonary hypertension after atrial septal defect closure: Impact of atrial fibrillation
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
13824.pdf
Boyut:
531.64 KB
Biçim:
Adobe Portable Document Format